Not cat, not morph, not dyax, not medx, not cll. pdli can't do fully human.
abgx?
Currently, Abgenix has three ongoing collaborations with Amgen: a codevelopment collaboration for ABX-EGF, a technology licensing agreement through which Amgen has advanced an antibody product candidate into clinical trials, and a discovery and development arrangement focused on developing antibodies to novel oncology targets.
Also, from 2001 abgx 10k:
Amgen: In April 1999, we entered into a research collaboration agreement with Amgen Inc., to generate fully human antibodies to an undisclosed antigen target. In 2000, Amgen exercised its option to acquire a product license. In December 2000, we extended our agreement to generate fully human antibodies to multiple antigen targets to be supplied by Amgen, during a five-year term. Also provided in the April 1999 agreement, Abgenix will perform the immunizations and certain research activities.
|
